Fertility and Sterility
Volume 90, Issue 5 , Pages 2004.e15-2004.e17 , November 2008

Ovarian hyperstimulation after a short course of an oral contraceptive in a patient with premature ovarian failure

  • Pavna Kartha Brahma, M.D.
    • ,
  • Caleb B. Kallen, M.D., Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests: Caleb B. Kallen, M.D., Ph.D., Emory University School of Medicine, Department of Gynecology and Obstetrics, Division of Reproductive Endocrinology and Infertility, 1639 Pierce Drive, WMB 4211, Atlanta, GA 30322 (FAX: 404-727-8609).

Received 10 March 2008 ,Revised 18 March 2008 ,Accepted 18 March 2008.

References 

  1. Anasti JN. Premature ovarian failure: an update. Fertil Steril. 1998;70:1–15
  2. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–606
  3. Nelson LM, Anasti JN, Kimzey LM, Defensor RA, Lipetz KJ, White BJ, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab. 1994;79:1470–1475
  4. van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 1999;5:483–492
  5. Laml T, Huber JC, Albrecht AE, Sintenis WA, Hartmann BW. Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone levels and amenorrhea. Gynecol Endocrinol. 1999;13:89–92
  6. Buckler HM, Healy DL, Burger HG. Does gonadotropin suppression result in follicular development in premature ovarian failure?. Gynecol Endocrinol. 1993;7:123–128
  7. Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G. Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril. 2007;87:858–861
  8. van Kasteren YM, Hoek A, Schoemaker J. Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertil Steril. 1995;64:273–278
  9. Anasti JN, Kimzey LM, Defensor RA, White B, Nelson LM. A controlled study of danazol for the treatment of karyotypically normal spontaneous premature ovarian failure. Fertil Steril. 1994;62:726–730
  10. Nelson LM, Kimzey LM, White BJ, Merriam GR. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertil Steril. 1992;57:50–55
  11. van Kasteren Y. Treatment concepts for premature ovarian failure. J Soc Gynecol Investig. 2001;8:S58–S59
  12. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril. 1996;65:337–341
  13. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotropic amenorrhea. Fertil Steril. 1990;53:804–810
  14. Dmowski WP, Michalowska J, Rana N, Friberg J, McGill-Johnson E, DeOrio L. Subcutaneous estradiol pellets for endometrial preparation in donor oocyte recipients with a poor endometrial response. J Assist Reprod Genet. 1997;14:139–144
  15. Letur-Konirsch H, Delanian S. Successful pregnancies after combined pentoxifylline-tocopherol treatment in women with premature ovarian failure who are resistant to hormone replacement therapy. Fertil Steril. 2003;79:439–441

 P.K.B. has nothing to disclose. C.B.K. has nothing to disclose.

PII: S0015-0282(08)00715-2

doi: 10.1016/j.fertnstert.2008.03.050

Fertility and Sterility
Volume 90, Issue 5 , Pages 2004.e15-2004.e17 , November 2008

Article Tools

* Image Usage & Resolution